Class I Recall of Abbott Acclaim and Hospira Acclaim Encore Infusion Pumps by Hospira: AttorneyOne Monitor and Keep Consumers Informed

On May 2, the FDA announced that Abbott Acclaim and Hospira Acclaim Encore Infusion Pumps, by Hospira, are recalled (Class I) due to broken door assemblies. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
Abbott Acclaim and Hospira Acclaim Encore Infusion Pumps Recalled

Abbott Acclaim and Hospira Acclaim Encore Infusion Pumps Recalled

use of the products included in the recall may cause serious injuries or death

San Diego, CA (PRWEB) June 10, 2014

AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for Infusion Pumps.

The FDA announced on May 2, that Abbott Acclaim and Hospira Acclaim Encore Infusion Pumps, by Hospira, are recalled (Class I) because broken door assemblies may result in over-infusion or delay of therapy. Use of these affected products may cause serious, life-threatening, adverse health consequences.

The affected products are:

  • Abbott Acclaim Infusion Pumps, list Number 12032. Manufacture dates: from February 1998 to November 1998, distribution dates: from September 1998 through February 2004.
  • Hospira Acclaim Encore infusion pumps list Number 12237. Manufacture dates: from February 1997 to February 2010, distribution dates from July 1999 through November 2013.
The FDA classified this recall as Class I, meaning use of the products included in the recall may cause serious injuries or death.

Taking into consideration the latest developments, AttorneyOne.com monitor daily and update the website providing accurate information on all relevant FDA safety alerts. Sean Burke, director of Media Relations at AttorneyOne.com, adds “We are determined to keep an eye on FDA announcements concerning Infusion Pumps and inform the public. For that reason," he continues, "our focus should squarely fall on investigating these safety alerts and getting the word out.”

As the FDA advises, “Hospira recommends that users inspect each Hospira/Abbott Acclaim Encore infusion pump for door handle cracks, prior to programming a therapy” by following specific steps. And the Agency adds that after following the specific steps “if you determine that a pump has a door that does not close correctly or if free flow is detected while the administration set is in the pump with the door closed, close the roller clamp, remove the pump from clinical service and call Hospira.”

AttorneyOne.com has further information on Infusion Pumps at the website including latest major drug and medical products law news.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/06/prweb11925813.htm